Equillium is Drug Discovery in United States that focus on product candidate business. Founded in 2017. They cover business area such as Equillium Inc, novel immune-modify therapy, severe immuno-inflammatory disease, its primary product candidate, itolizumab, pathway, trafficking, inflammation, a number, Itolizumab, multiple severe immuno-inflammatory disorder, graft, host disease, severe asthma, SLE, lupus nephritis.
2017
( 7 years old in 2024 )
Product Candidate
-
2223 Avenida De La Playa
Suite 108
La Jolla, CA 92037
United States
Private
Equillium Incnovel immune-modify therapysevere immuno-inflammatory diseaseits primary product candidateitolizumabpathwaytraffickinginflammationa numberItolizumabmultiple severe immuno-inflammatory disordergrafthost diseasesevere asthmaSLElupus nephritis
* We use standard office opening hours in near Equillium's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Equillium is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Equillium business is focusing on Product Candidate.
Equillium headquarter office and corporate office address is located in 2223 Avenida De La Playa Suite 108 La Jolla, CA 92037 United States.
Equillium was founded in United States.
In 2024, Equillium is currently focus on product candidate sector.
Above is snippet of Google Trends for "product candidate" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Equillium, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
